Learning Outcomes

1. Implement safe and effective opioid prescribing as part of a broader pain management plan.1
2. Summarise the potential benefits and risks associated with opioid prescribing.
3. Recognise, prevent, and respond to problematic pharmaceutical opioid use.
4. Assess the appropriateness of and commence induction of a patient on one of the Opioid Replacement Therapies - Buprenorphine.

This module will be completed online before attending the face-to-face component of the workshop.

 

Learning Outcomes

1. Assess patients presenting with problematic opioid use.
2. Outline the criteria for the diagnosis of Opioid Use Disorder.
3. Address the legislative requirements relating to prescribing of buprenorphine and methadone.
4. Implement opioid and methadone prescribing as part of a broader Opioid Use Disorder management plan.
5. Describe MATOD-related referral and support pathways.

This module will be partially completed online prior to attending the face-to-face component of the workshop.

On completion of modules 1 and 2 prescribers will be trained and recognised as an authorised prescriber for methadone and buprenorphine based assisted treatment of opioid dependence.

Learning Outcomes

1. Correctly interpret legislative frameworks and evidence-based clinical guidelines for the use of Long-Acting Injection Buprenorphine.
2. Describe the options available for opioid dependent people who are considering Long-Acting Injection Buprenorphine.
3. Apply pharmaceutical knowledge and rationale to the prescribing principles for Long-Acting Injection Buprenorphine.

On completion of modules 1 and 2 prescribers will be trained and recognised as an authorised prescriber for methadone and buprenorphine based assisted treatment of opioid dependence.

Module 3 is an optional component that can be completed in addition to the previous modules.